Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Liabilities (2016 - 2025)

CorMedix has reported Total Liabilities over the past 16 years, most recently at $420.8 million for Q4 2025.

  • Quarterly results put Total Liabilities at $420.8 million for Q4 2025, up 1130.91% from a year ago — trailing twelve months through Dec 2025 was $420.8 million (up 1130.91% YoY), and the annual figure for FY2025 was $420.8 million, up 1130.91%.
  • Total Liabilities reached $420.8 million in Q4 2025 per CRMD's latest filing, up from $376.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $420.8 million in Q4 2025 and bottomed at $3.9 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $8.1 million (2023), compared with a mean of $50.8 million.
  • The largest annual shift saw Total Liabilities crashed 32.08% in 2021 before it skyrocketed 1896.05% in 2025.
  • Over 5 years, Total Liabilities stood at $6.1 million in 2021, then rose by 13.52% to $7.0 million in 2022, then skyrocketed by 70.77% to $11.9 million in 2023, then skyrocketed by 186.88% to $34.2 million in 2024, then soared by 1130.91% to $420.8 million in 2025.
  • Business Quant data shows Total Liabilities for CRMD at $420.8 million in Q4 2025, $376.7 million in Q3 2025, and $32.0 million in Q2 2025.